SOPHiA GENETICS Prices $50M Share Offering at $4.75
SOPH•SOPHiA GENETICS priced an underwritten public offering of 10.526 million ordinary shares at $4.75 per share, raising approximately $50 million in gross proceeds before fees. The underwriters received a 30-day option to buy up to 1.5789 million additional shares at the same price, with closing set for June 18, 2026.
1. Offering Details
SOPHiA GENETICS has launched an underwritten public offering of 10.526 million ordinary shares priced at $4.75 each, positioning the company to raise gross proceeds of roughly $50 million before underwriting discounts and commissions.
2. Overallotment Option and Expected Closing
The company granted underwriters a 30-day option to purchase up to 1.5789 million additional shares at $4.75 per share, and plans to close the offering on June 18, 2026, subject to customary conditions.
3. Registration and Management
A Form F-3 registration statement was declared effective on August 15, 2025, authorizing the sale under a prospectus supplement; TD Cowen serves as lead book-running manager alongside Guggenheim Securities, BTIG and Craig-Hallum.
